What clinical trials do small biotech companies need to perform, to get to proof of concept?

Join us for our free lunch & educational seminar where we are bringing together our experts in clinical drug development for a half day of learning. If you would like to learn more about how to navigate the transition from pre-clinical to clinical research & development, please register below. Reducing time to market and increasing the chances of a drug’s success are essential for pharmaceutical companies of all sizes. Asking the right questions is essential for small biotech companies approaching the clinical phase, that's why our experts will address the whos, whats, where, whens, and hows of clinical research. Register below before our limited seating runs out. The exact agenda will be release soon.

Agenda:

11:30 – 13:00
Registration/lunch

13:00 – 13:10
Intro by Antonio

13:10 – 13:45
TPP Driven Drug Development Sven

13:45 – 14:15
Regulatory Overview by Gunnar

Break (5 min) legs stretch

14:20 – 15:00
Clinical Design considerations by Gunnar

15:00 – 15:20
Dose finding by Malin

Break (20 min)

15:40 – 16:00
eSource and Viedoc by Sverre

16:00 – 16:30
Panel Discussion, moderated by Antonio

16:30 - 16:40
Conclusion by Sverre

16:40 – 18:30
Mingle, fika, drinks, and gl�gg

We look forward to seeing you here!

Learn about our excellent speaker line up:

Sverre Bengtsson Co-founder, Sr. VP, Strategic Relations, Chairman of the Board for the PCG group of companies.
Sverre Bengtsson is one of our Co-founders and has served as a member of our board of directors since our inception in March 2003. Sverre holds an MBA from the University of Gothenburg, Sweden, and has more than 20 years of experience in clinical research.

Gunnar Danielsson Sr. Regulatory Advisor

Gunnar has a BSc in Natural Science and almost 40 years’ experience in Clinical Research. Gunnar served as a renowned GCP Inspector for the Swedish MPA for over 10 years, and has a wealth of experience from the Pharmaceutical industry in terms of quality management, electronic systems, data management, and clinical design and conduct. Gunnar is a key advisory resource and he helps to design studies in the most effective way, meeting regulatory requirements.

Sven Undeland, owner at FHC Undeland and partner at PCG Clinical Services
Sven has a broad commercial and clinical development experience from international pharmaceutical industry, based on leading positions in Pharmacia, AstraZeneca and Orexo. Sven’s strength is to give strategic commercial support in life science projects during development, to prepare the projects for successful licensing or launch. In addition, Sven has five years’ experience from business development and has successfully negotiated and completed several licensing deals. Sven has a Master in Science (M.Sc) in Chemical and Administrative Sciences.

Malin Schollin

Malin Schollin Team Leader Biostatistics, PCG Clinical Services
Malin has a MSc in Mathematics from the University of Uppsala, she has been working as a biostatistician within Pharmaceutical industry for 10 years within all clinical phases. She has lead challenging projects at PCG since 2012 and has also worked at AstraZeneca and Quintiles.

Antonio Mastroianni, Business Developer at PCG Clinical Services
Antonio has 20 years of multi-sector experience in government, non-profit, standard-setting bodies, and for-profit organizations. Over the course of working with various organizations across the US and Europe Antonio has specialized in IT/Telecom management consulting and Healthcare. His primary focus today with PCG Clinical Service is in partnership management, business development, and transformation.

• 7 years of experience working in non-profit sector
• 11 years of experience in corporate America
• 5 years of experience at the national and state level of US government and with international standard setting bodies
• 6 years working in global healthcare improvement
• 7 years in relationship management and business development